OptiNose Management

Management criteria checks 2/4

OptiNose's CEO is Ramy Mahmoud, appointed in Jan 2023, has a tenure of 1.92 years. total yearly compensation is $2.41M, comprised of 26.8% salary and 73.2% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth $151.28K. The average tenure of the management team and the board of directors is 2.3 years and 3 years respectively.

Key information

Ramy Mahmoud

Chief executive officer

US$2.4m

Total compensation

CEO salary percentage26.8%
CEO tenure1.9yrs
CEO ownership0.2%
Management average tenure2.3yrs
Board average tenure3yrs

Recent management updates

Recent updates

OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 31%

Nov 26
OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 31%

Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50

Nov 15
Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50

Slammed 34% OptiNose, Inc. (NASDAQ:OPTN) Screens Well Here But There Might Be A Catch

Sep 27
Slammed 34% OptiNose, Inc. (NASDAQ:OPTN) Screens Well Here But There Might Be A Catch

Market Cool On OptiNose, Inc.'s (NASDAQ:OPTN) Revenues Pushing Shares 30% Lower

Aug 11
Market Cool On OptiNose, Inc.'s (NASDAQ:OPTN) Revenues Pushing Shares 30% Lower

Not Many Are Piling Into OptiNose, Inc. (NASDAQ:OPTN) Stock Yet As It Plummets 42%

Apr 27
Not Many Are Piling Into OptiNose, Inc. (NASDAQ:OPTN) Stock Yet As It Plummets 42%

There's Reason For Concern Over OptiNose, Inc.'s (NASDAQ:OPTN) Massive 32% Price Jump

Mar 01
There's Reason For Concern Over OptiNose, Inc.'s (NASDAQ:OPTN) Massive 32% Price Jump

Revenues Working Against OptiNose, Inc.'s (NASDAQ:OPTN) Share Price

Dec 28
Revenues Working Against OptiNose, Inc.'s (NASDAQ:OPTN) Share Price

OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 29%

May 23
OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 29%

The Consensus EPS Estimates For OptiNose, Inc. (NASDAQ:OPTN) Just Fell Dramatically

Mar 09
The Consensus EPS Estimates For OptiNose, Inc. (NASDAQ:OPTN) Just Fell Dramatically

OptiNose GAAP EPS of -$0.23 beats by $0.01, revenue of $20.6M misses by $0.9M

Aug 11

OptiNose: Potential Winner In Chronic Sinusitis Treatment

Jun 16

OptiNose: Underappreciated Potential

Mar 10

CEO Compensation Analysis

How has Ramy Mahmoud's remuneration changed compared to OptiNose's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$31m

Jun 30 2024n/an/a

-US$41m

Mar 31 2024n/an/a

-US$31m

Dec 31 2023US$2mUS$647k

-US$35m

Sep 30 2023n/an/a

-US$41m

Jun 30 2023n/an/a

-US$46m

Mar 31 2023n/an/a

-US$68m

Dec 31 2022US$1mUS$504k

-US$75m

Sep 30 2022n/an/a

-US$75m

Jun 30 2022n/an/a

-US$77m

Mar 31 2022n/an/a

-US$82m

Dec 31 2021US$1mUS$504k

-US$82m

Sep 30 2021n/an/a

-US$91m

Jun 30 2021n/an/a

-US$95m

Mar 31 2021n/an/a

-US$97m

Dec 31 2020US$2mUS$489k

-US$100m

Sep 30 2020n/an/a

-US$101m

Jun 30 2020n/an/a

-US$109m

Mar 31 2020n/an/a

-US$110m

Dec 31 2019US$1mUS$475k

-US$110m

Sep 30 2019n/an/a

-US$111m

Jun 30 2019n/an/a

-US$108m

Mar 31 2019n/an/a

-US$105m

Dec 31 2018US$609kUS$451k

-US$107m

Sep 30 2018n/an/a

-US$101m

Jun 30 2018n/an/a

-US$93m

Mar 31 2018n/an/a

-US$81m

Dec 31 2017US$3mUS$438k

-US$62m

Compensation vs Market: Ramy's total compensation ($USD2.41M) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Ramy's compensation has increased whilst the company is unprofitable.


CEO

Ramy Mahmoud (59 yo)

1.9yrs

Tenure

US$2,414,265

Compensation

Dr. Ramy A. Mahmoud, M.D., M.P.H., serves as Chief Executive Officer and Director of OptiNose US Inc. since January 2023. He serves as Chief Executive Officer & Director of OptiNose, Inc. since January 31,...


Leadership Team

NamePositionTenureCompensationOwnership
Ramy Mahmoud
CEO & Director1.9yrsUS$2.41m0.24%
$ 151.3k
Michael Marino
Chief Legal Officer & Corporate Secretary7.9yrsUS$1.32m0.10%
$ 65.7k
Paul Spence
Chief Commercial Officer2yrsUS$664.02k0%
$ 0
P. Terence Kohler
Chief Financial Officerless than a yearno datano data
Anthony Krick
VP of Finance & Chief Accounting Officer2.5yrsno data0.0033%
$ 2.1k
Jonathan Neely
Vice President of Investor Relations & Business Developmentno datano datano data
Karen Brophy
Chief Human Resources Officer & VP of Human Resources6.8yrsno datano data

2.3yrs

Average Tenure

56yo

Average Age

Experienced Management: OPTN's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ramy Mahmoud
CEO & Director1.9yrsUS$2.41m0.24%
$ 151.3k
Sandra Helton
Independent Director6.8yrsUS$103.42k0%
$ 0
R. Fletcher
Independent Chairman2.7yrsUS$120.22k0%
$ 0
Eric Bednarski
Independent Director3yrsUS$88.42k0%
$ 0
Wilhelmus C. Groenhuysen
Independent Director7.2yrsUS$100.92k0%
$ 0
Tomas Heyman
Independent Director4yrsUS$96.88k0%
$ 0
Kyle Dempsey
Independent Director3yrsUS$90.92k0%
$ 0

3.0yrs

Average Tenure

67yo

Average Age

Experienced Board: OPTN's board of directors are considered experienced (3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 20:52
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OptiNose, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gary NachmanBMO Capital Markets Equity Research
John TannerCantor Fitzgerald & Co.
Matthew CaufieldH.C. Wainwright & Co.